Influenza, management and treatment Key facts Chair(s): Barbara Rath, Besancon, France Approval date: December 2019 Expected completion: April 2025 Comment: Last status report date: 24.06.2024 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing…
Get to know moreDosing of antimicrobials in patient with renal impairment with or without RRT Key facts Chair(s): Thomas Tängdén, Uppsala, Sweden Approval date: March 2023 Expected completion: April 2025 Comment: Last status report date: 24.06.2024 Status Report Guideline Development Steps Status Guideline Group…
Get to know moreGuidelines in development We work throughout the year to propose and endorse quality guidelines to our members and the global professional community. Below is a list of guidance documents that are currently under development. Dive deeper into the details of each guidance document and follow the…
Get to know moreOPENING Project: IncOrPorating Ethics iN ClINical Guidelines: Practical Indications Key facts Chair(s): Elda Righi, Verona, Italy Approval date: October 2022 Expected completion: December 2024 Comment: Last status report date: 15.03.2024 Status Report Guideline Development Steps Status Establishing…
Get to know moreOnline course By kind permission of the Cochrane group and McMaster University, we are able to make available on our website the modules on principles of the GRADE methodology, a useful tool for all ESCMID members involved in guidelines development and systematic reviews and/or performing systematic…
Get to know moreESCMID Consensus document for management of COVID-19 in immunocompromised patients Key facts Chair(s): Michele Bartoletti, Bologna, Italy and Roy Chemaly, Houston, United States Approval date: May 2022 Expected completion: December 2024 Comment: Last status report date: 15.03.2024 Status Report…
Get to know more